Health experts are alarmed as Republicans degrade the country’s pivotal HIV programs — and break promises made during Trump’s ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...
Rutgers Health researchers found that prescription rates for preexposure prophylaxis rose overall, but racial disparities ...
Zacks Investment Research on MSN
GILD's Investigational Regimen for HIV Treatment Meets Primary Goal
Gilead Sciences, Inc. GILD announced that its investigational single-tablet regimen (STR) of bictegravir and lenacapavir for ...
Opinion
16dOpinion
HIV knows no borders, and the Trump administration’s new strategy leave Americans vulnerable – an HIV-prevention expert explains
The Trump administration’s new global HIV prevention strategy prioritizes preventing mother-to-child HIV transmission. About 120,000 children under the age of 5 were newly infected with HIV in 2024, ...
Sara Paparini has received funding from ViiV Healthcare and Gilead Sciences. Sophie Strachan receives funding from ViiV and Gilead and MSD she is affiliated with Sophia Forum Rosalie Hayes does not ...
Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects. Patrick Sullivan, DVM, PhD, an infectious disease ...
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback